Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00528684
Recruitment Status : Completed
First Posted : September 12, 2007
Last Update Posted : October 2, 2014
Sponsor:
Information provided by (Responsible Party):
Oncolytics Biotech

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2010
Actual Study Completion Date : June 2010